// App-Quantinova.ai

OP16 : A randomised, multi-centre, double-blind, placebo-controlled study of a targeted release oral cyclosporine formulation in the treatment of mild-to-moderate ulcerative colitis: efficacy results

Researchers

Presenter

  • S Bloom

Principal Investigators

  • T Iqbal

  • C Nwokolo

  • M Smith

  • D ODonoghue

  • J Hall

  • B Dzyngel

Medical Centers

  • University College Hospital, London,

  • Queen Elizabeth Hospital Birmingham, Birmingham,

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • Shrewsbury and Telford Hospital, Shrewsbury, UK

  • St. Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland

  • Sublimity Therapeutics, Solana Beach, USA

Locations

  • United Kingdom

  • Ireland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Cyclosporine eent

  • ST-0529

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved